IIN Stock Overview
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$15.95|
|52 Week High||US$28.16|
|52 Week Low||US$14.89|
|1 Month Change||-14.57%|
|3 Month Change||-25.36%|
|1 Year Change||-12.46%|
|3 Year Change||-48.33%|
|5 Year Change||141.67%|
|Change since IPO||187.82%|
Recent News & Updates
IntriCon (NASDAQ:IIN) Might Be Having Difficulty Using Its Capital Effectively
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
IntriCon Corporation's (NASDAQ:IIN) Intrinsic Value Is Potentially 91% Above Its Share Price
In this article we are going to estimate the intrinsic value of IntriCon Corporation ( NASDAQ:IIN ) by taking the...
The Strong Earnings Posted By IntriCon (NASDAQ:IIN) Are A Good Indication Of The Strength Of The Business
Even though IntriCon Corporation's ( NASDAQ:IIN ) recent earnings release was robust, the market didn't seem to notice...
|IIN||US Medical Equipment||US Market|
Return vs Industry: IIN underperformed the US Medical Equipment industry which returned 8.9% over the past year.
Return vs Market: IIN underperformed the US Market which returned 16.5% over the past year.
|IIN Average Weekly Movement||7.1%|
|Medical Equipment Industry Average Movement||7.6%|
|Market Average Movement||6.2%|
|10% most volatile stocks in US Market||14.8%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: IIN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: IIN's weekly volatility (7%) has been stable over the past year.
About the Company
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology, and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers.
IntriCon Fundamentals Summary
|IIN fundamental statistics|
Is IIN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IIN income statement (TTM)|
|Cost of Revenue||US$92.27m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.11|
|Net Profit Margin||0.78%|
How did IIN perform over the long term?See historical performance and comparison
Is IntriCon undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IIN ($15.95) is trading below our estimate of fair value ($41.26)
Significantly Below Fair Value: IIN is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: IIN is poor value based on its PE Ratio (151.3x) compared to the US Medical Equipment industry average (44.6x).
PE vs Market: IIN is poor value based on its PE Ratio (151.3x) compared to the US market (16.8x).
Price to Earnings Growth Ratio
PEG Ratio: IIN is poor value based on its PEG Ratio (1.3x)
Price to Book Ratio
PB vs Industry: IIN is good value based on its PB Ratio (1.6x) compared to the US Medical Equipment industry average (3.7x).
How is IntriCon forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IIN's forecast earnings growth (118.7% per year) is above the savings rate (2%).
Earnings vs Market: IIN's earnings (118.7% per year) are forecast to grow faster than the US market (13.8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IIN's revenue (13.1% per year) is forecast to grow faster than the US market (9.8% per year).
High Growth Revenue: IIN's revenue (13.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IIN's Return on Equity is forecast to be high in 3 years time
How has IntriCon performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IIN has a large one-off loss of $3.1M impacting its September 30 2021 financial results.
Growing Profit Margin: IIN became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: IIN has become profitable over the past 5 years, growing earnings by -11.7% per year.
Accelerating Growth: IIN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: IIN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (51.2%).
Return on Equity
High ROE: IIN's Return on Equity (1.1%) is considered low.
How is IntriCon's financial position?
Financial Position Analysis
Short Term Liabilities: IIN's short term assets ($79.3M) exceed its short term liabilities ($21.5M).
Long Term Liabilities: IIN's short term assets ($79.3M) exceed its long term liabilities ($9.0M).
Debt to Equity History and Analysis
Debt Level: IIN is debt free.
Reducing Debt: IIN has no debt compared to 5 years ago when its debt to equity ratio was 44.2%.
Debt Coverage: IIN has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IIN has no debt, therefore coverage of interest payments is not a concern.
What is IntriCon current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IIN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IIN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IIN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IIN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IIN's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
J. Longval (44 yo)
Mr. J. Scott Longval has been Chief Executive Officer, President and Director of IntriCon Corporation since October 1, 2020. He served as an Executive Vice President at IntriCon Corporation until September...
CEO Compensation Analysis
Compensation vs Market: J.'s total compensation ($USD650.07K) is about average for companies of similar size in the US market ($USD567.11K).
Compensation vs Earnings: J.'s compensation has been consistent with company performance over the past year.
Experienced Management: IIN's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: IIN's board of directors are considered experienced (3.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
IntriCon Corporation's employee growth, exchange listings and data sources
- Name: IntriCon Corporation
- Ticker: IIN
- Exchange: NasdaqGM
- Founded: 1930
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$145.833m
- Shares outstanding: 9.14m
- Website: https://www.intricon.com
Number of Employees
- IntriCon Corporation
- 1260 Red Fox Road
- Arden Hills
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/12/07 00:19|
|End of Day Share Price||2021/12/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.